These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28559277)

  • 21. Ethanolic Extract Propolis-Loaded Niosomes Diminish Phospholipase B1, Biofilm Formation, and Intracellular Replication of
    Kietrungruang K; Sookkree S; Sangboonruang S; Semakul N; Poomanee W; Kitidee K; Tragoolpua Y; Tragoolpua K
    Molecules; 2023 Aug; 28(17):. PubMed ID: 37687052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritization.
    Ianiri G; Idnurm A
    mBio; 2015 Mar; 6(2):. PubMed ID: 25827419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNP Analogues Inhibit the Virulence Promoting IP
    Desmarini D; Truong D; Wilkinson-White L; Desphande C; Torrado M; Mackay JP; Matthews JM; Sorrell TC; Lev S; Thompson PE; Djordjevic JT
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans.
    Rude TH; Toffaletti DL; Cox GM; Perfect JR
    Infect Immun; 2002 Oct; 70(10):5684-94. PubMed ID: 12228298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling Caspofungin Resistance in Cryptococcus neoformans.
    Papon N; Goldman GH
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727346
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure of a fungal form of aspartate semialdehyde dehydrogenase from Cryptococcus neoformans.
    Dahal G; Viola RE
    Acta Crystallogr F Struct Biol Commun; 2015 Nov; 71(Pt 11):1365-71. PubMed ID: 26527262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the
    Tancer RJ; Wang Y; Pawar S; Xue C; Wiedman GR
    Microbiol Spectr; 2022 Apr; 10(2):e0043922. PubMed ID: 35377230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents.
    Juvvadi PR; Fox D; Bobay BG; Hoy MJ; Gobeil SMC; Venters RA; Chang Z; Lin JJ; Averette AF; Cole DC; Barrington BC; Wheaton JD; Ciofani M; Trzoss M; Li X; Lee SC; Chen YL; Mutz M; Spicer LD; Schumacher MA; Heitman J; Steinbach WJ
    Nat Commun; 2019 Sep; 10(1):4275. PubMed ID: 31537789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.
    Rittershaus PC; Kechichian TB; Allegood JC; Merrill AH; Hennig M; Luberto C; Del Poeta M
    J Clin Invest; 2006 Jun; 116(6):1651-9. PubMed ID: 16741577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Genome Editing via CRISPR in the Pathogen Cryptococcus neoformans.
    Arras SD; Chua SM; Wizrah MS; Faint JA; Yap AS; Fraser JA
    PLoS One; 2016; 11(10):e0164322. PubMed ID: 27711143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Environmental Effects on Virulence Factors and the Antifungal Susceptibility of
    Momin M; Webb G
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208294
    [No Abstract]   [Full Text] [Related]  

  • 32. Glutathione-mediated redox regulation in Cryptococcus neoformans impacts virulence.
    Black B; da Silva LBR; Hu G; Qu X; Smith DFQ; Magaña AA; Horianopoulos LC; Caza M; Attarian R; Foster LJ; Casadevall A; Kronstad JW
    Nat Microbiol; 2024 Aug; 9(8):2084-2098. PubMed ID: 38956248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulating PHO Signaling via the CDK Machinery Differentially Impacts Energy Metabolism, Calcineurin Signaling, and Virulence in Cryptococcus neoformans.
    Bowring BG; Sethiya P; Desmarini D; Lev S; Tran Le L; Bahn YS; Lee SH; Toh-E A; Proschogo N; Savage T; Djordjevic JT
    mBio; 2023 Apr; 14(2):e0355122. PubMed ID: 37017534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of Antifungal Mechanisms of Thymol in the Human Fungal Pathogen,
    Jung KW; Chung MS; Bai HW; Chung BY; Lee S
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34200464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring Urease and Phospholipase Secretion in Cryptococcus neoformans.
    Hoffman HJ; McClelland EE
    Methods Mol Biol; 2024; 2775():269-275. PubMed ID: 38758324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and kinetic characterization of xylulose 5-phosphate/fructose 6-phosphate phosphoketolase 2 (Xfp2) from Cryptococcus neoformans.
    Glenn K; Ingram-Smith C; Smith KS
    Eukaryot Cell; 2014 May; 13(5):657-63. PubMed ID: 24659577
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Beattie SR; Jezewski AJ; Ristow LC; Wellington M; Krysan DJ
    mSphere; 2022 Jun; 7(3):e0016322. PubMed ID: 35506343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcimycin Inhibits
    Tharappel AM; Li Z; Zhu YC; Wu X; Chaturvedi S; Zhang QY; Li H
    ACS Infect Dis; 2022 Sep; 8(9):1851-1868. PubMed ID: 35948057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Waste to drugs: identification of pyrolysis by-products as antifungal agents against
    Krishnan S; Gupta K; Sivaraman S; Venkatachalam P; Yennamalli RM; Shanmugam SR
    J Biomol Struct Dyn; 2023; 41(24):15386-15399. PubMed ID: 36927454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isobavachalcone: A redox antifungal agent impairs the mitochondria protein of Cryptococcus neoformans.
    Wang X; Zhou WT; Dong HH; Li CY; Jiang YY; Xie P; Xu ZY; Xie SH; Yang SX; Huang L; Chen H; Wang LY; Wei X; Huang YQ
    Int J Antimicrob Agents; 2024 Aug; 64(2):107253. PubMed ID: 38925229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.